cyclopentane has been researched along with alprostadil in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Okano, K; Sakai, K; Suemune, H | 1 |
| Egashira, H; Harada, H; Ishida, A; Kondo, K; Maruyama, T; Naganawa, A; Nakai, H; Ogawa, M; Ohuchida, S; Sagawa, K; Tani, K; Toda, M | 1 |
| Bit, RA; Brown, SH; Chaignot, HM; Chessell, IP; Chowdhury, A; Clayton, NM; Coleman, T; Giblin, GM; Hall, A; Hammond, B; Hurst, DN; Michel, AD; Naylor, A; Novelli, R; Scoccitti, T; Spalding, D; Tang, SP; Wilson, AW; Wilson, R | 1 |
3 other study(ies) available for cyclopentane and alprostadil
| Article | Year |
|---|---|
Preparation of chiral, highly functionalized cyclopentanes and its application to the synthesis of prostaglandin E1.
Topics: Alprostadil; Chemical Phenomena; Chemistry; Cyclopentanes | 1989 |
Design and synthesis of a highly selective EP2-receptor agonist.
Topics: Alprostadil; Animals; Binding Sites; CHO Cells; Cricetinae; Cyclic AMP; Cyclobutanes; Cyclopentanes; Dinoprostone; Drug Design; Female; Humans; Ligands; Mice; Rats; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP2 Subtype; Sensitivity and Specificity; Uterine Contraction | 2001 |
The discovery of 6-[2-(5-chloro-2-{[(2,4-difluorophenyl)methyl]oxy}phenyl)-1-cyclopenten-1-yl]-2-pyridinecarboxylic acid, GW848687X, a potent and selective prostaglandin EP1 receptor antagonist for the treatment of inflammatory pain.
Topics: Alprostadil; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Availability; Cyclopentanes; Cytochrome P-450 Enzyme System; Dogs; Dose-Response Relationship, Drug; Freund's Adjuvant; Half-Life; Inflammation; Pain; Pyridines; Rats; Receptors, Prostaglandin E | 2007 |